What is Leerink Partnrs’ Estimate for ARDT FY2028 Earnings?

Ardent Health Partners, LLC (NYSE:ARDT) – Stock analysts at Leerink Partnrs issued their FY2028 earnings per share (EPS) estimates for Ardent Health Partners in a research report issued on Thursday, April 24th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings per share of $2.61 for the year. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share.

A number of other research firms also recently commented on ARDT. Guggenheim initiated coverage on Ardent Health Partners in a report on Wednesday, April 9th. They issued a “buy” rating and a $16.00 target price for the company. Mizuho decreased their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 9th. Royal Bank of Canada dropped their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Tuesday, March 4th. Stephens reaffirmed an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Finally, Truist Financial lowered their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $20.58.

Ardent Health Partners Trading Up 0.5 %

Ardent Health Partners stock opened at $12.61 on Monday. Ardent Health Partners has a one year low of $11.31 and a one year high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The business has a fifty day moving average of $13.26 and a two-hundred day moving average of $15.27.

Ardent Health Partners (NYSE:ARDT) last released its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion.

Hedge Funds Weigh In On Ardent Health Partners

Several institutional investors and hedge funds have recently modified their holdings of ARDT. State Street Corp purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $1,977,000. Jane Street Group LLC purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $567,000. Barclays PLC purchased a new position in Ardent Health Partners during the third quarter worth approximately $385,000. Geode Capital Management LLC purchased a new position in Ardent Health Partners during the third quarter worth approximately $2,581,000. Finally, Franklin Resources Inc. purchased a new position in Ardent Health Partners during the third quarter worth approximately $15,839,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.